Investor Relations

Founded by some of the world's most renowned specialists in cancer diagnosis, treatment and research, Champions Oncology (OCTBB:CSBR) is engaged in the development of advanced technologies to enhance the personalized treatment of human cancers. Based on the proprietary Champions Personalized TumorGraft™ technology, Champions offers cancer patients and their physicians—as well as cancer researchers—powerful tools to more effectively guide cancer treatments for patients and the development of new cancer drugs.

Filing Detail:

Document Format Files:

Seq Description Document Type Size
1 FORM 10-Q v242153_10q.htm 10-Q 658981
2 EXHIBIT 31.1 v242153_ex31-1.htm EX-31.1 20205
3 EXHIBIT 31.2 v242153_ex31-2.htm EX-31.2 20915
4 EXHIBIT 32.1 v242153_ex32-1.htm EX-32.1 9254
  Complete submission text file 0001144204-11-069762.txt   2376053

Data Files:

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT csbr-20111031.xml EX-101.INS 288571
6 XBRL TAXONOMY EXTENSION SCHEMA csbr-20111031.xsd EX-101.SCH 15620
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE csbr-20111031_cal.xml EX-101.CAL 23533
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE csbr-20111031_def.xml EX-101.DEF 52769
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE csbr-20111031_lab.xml EX-101.LAB 127306
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE csbr-20111031_pre.xml EX-101.PRE 72547

Please contact Susan Foreman at Champions Oncology, Inc., for investor information or to arrange to communicate with Company principals..

Susan Foreman
Champions Oncology, Inc.
E-mail: sforeman@championsoncology.com
Phone: 410.369.0365

Corporate Governance

Charters:

 

References:

  1. Hidalgo M et al. Activity of gemcitabine in direct patient derived xenografts predicts clinical outcome: validation of an in vivo model for drug development. J Clin Oncol 27:15s, 2009 (suppl; abstr 4528)
  2. Hidalgo M et al. A Pilot Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer. Mol Cancer Ther August 2011 10:1311-1316
  3. Rubio-Viqueira B, Jimeno A, Cusatis G, et al. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12:4652-4661.
  4. Champions data on file.